International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Published on Feb 1, 2006in Journal of Thrombosis and Haemostasis5.824
· DOI :10.1111/J.1538-7836.2006.01753.X
Rhwm Derksen5
Estimated H-index: 5
(UU: Utrecht University)
Summary. New clinical, laboratory and experimental insights, since the 1999 publication of the Sapporo preliminary classification criteria for antiphospholipid syndrome (APS), had been addressed at a workshop in Sydney, Australia, before the Eleventh International Congress on antiphospholipid antibodies. In this document, we appraise the existing evidence on clinical and laboratory features of APS addressed during the forum. Based on this, we propose amendments to the Sapporo criteria. We also provide definitions on features of APS that were not included in the updated criteria.
Figures & Tables
đź“– Papers frequently viewed together
15 Authors (Vittorio Pengo, ..., Sabino Iliceto)
#1Christoph Male (Medical University of Vienna)H-Index: 33
#2Denise FoulonH-Index: 1
Last. Lesley G. MitchellH-Index: 23
view all 7 authors...
Study objectives were to determine, in children with systemic lupus erythematosus (SLE), (1) the association of antiphosholipid antibody (APLA) subtypes with thrombotic events (TEs) and (2) the predictive value of persistent versus transient antibodies for TEs. This is a cohort study of 58 SLE children in whom lupus anticoagulants (LAs), anticardiolipin antibodies (ACLAs), anti–β 2 -glycoprotein-I (anti–β 2 -GPI), and antiprothrombin (anti-PT) were assessed on at least 2 occasions (more than 3 m...
#1Elias ToubiH-Index: 52
#2Ilan KrauseH-Index: 34
Last. Yehuda Shoenfeld (TAU: Tel Aviv University)H-Index: 147
view all 8 authors...
Objective Livedo reticularis (LR) is a skin vasculopathy that has been frequently described in patients with anti-phospholipid syndrome (APS) and reported to be present in association with valvular heart pathology and strokes (i.e. Sneddon’s syndrome). Methods In a cohort of APS patients we investigated the possible association of LR with various clinical aspects of APS such as pregnancy morbidity, central nervous system (CNS) and cardiac manifestations. Results Livedo reticularis was found in 5...
#1E. Y. McLaurinH-Index: 1
#2S. L. HollidayH-Index: 3
Last. Robin L. BreyH-Index: 43
view all 4 authors...
Objective: To evaluate predictors of cognitive dysfunction in patients with systemic lupus erythematosus (SLE). Methods: The authors evaluated 123 patients enrolled in the San Antonio Lupus Study of Neuropsychiatric Disease (SALUD) who had completed at least 3 years of follow-up. Study visits occurred every 4 months and included a standard medical history, physical examination, and cognitive testing. Blood was obtained at each study visit for autoantibody testing. Results: There were 116 (94.3%)...
#1H. Bas de LaatH-Index: 2
Last. Philip G. de Groot (University Medical Center Utrecht)H-Index: 77
view all 5 authors...
The antiphospholipid syndrome is characterized by the presence of antiphospholipid antibodies in plasma of patients with thromboembolic complications. A major problem in defining the syndrome is that serologic assays to detect antiphospholipid antibodies have a low specificity. We recently published a method that specifically detects lupus anticoagulant (LAC) caused by anti–β 2 -glycoprotein I antibodies. Here, we studied the clinical relevance of detecting β 2 -glycoprotein I–dependent LAC. Pla...
#1Guillermina Girardi (HSS: Hospital for Special Surgery)H-Index: 38
#2Patricia Redecha (HSS: Hospital for Special Surgery)H-Index: 28
Last. Jane E. Salmon (HSS: Hospital for Special Surgery)H-Index: 86
view all 3 authors...
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
#1Guido Reber (Geneva College)H-Index: 44
#2A. Tincani (Geneva College)H-Index: 1
Last. Marie-Claire BoffaH-Index: 15
view all 5 authors...
#1Gerlinde ObermoserH-Index: 11
#2Waltraud Bitterlich (University of Salzburg)H-Index: 1
Last. Norbert SeppH-Index: 28
view all 4 authors...
Background: Anticardiolipin (aCl) and anti-β2-glycoprotein I (anti-β2-gpI) antibodies are autoantibodies associated with the antiphospholipid syndrome (APS), w
#1M. J. N. Diogenes (UFC: Federal University of Ceará)H-Index: 6
#2Pedro Coelho Nogueira Diógenes (UFC: Federal University of Ceará)H-Index: 2
Last. Rosangela R. A. Holanda (UFC: Federal University of Ceará)H-Index: 1
view all 6 authors...
Background Primary Antiphospholipid Antibody Syndrome (PAAS) is characterized by detection of antiphospholipid antibodies associated with venous or arterial thrombosis and/or miscarriages by patients with no other associated disease such as systemic lupus erythematosus (SLE). Primary Antiphospholipid Antibody Syndrome has many clinical manifestations of which dermatological ones are probably the most common. The purpose of this study was to determine the frequency of each cutaneous lesion, descr...
#1Maria G Tektonidou (UoA: National and Kapodistrian University of Athens)H-Index: 48
#2Flora SotsiouH-Index: 4
Last. Haralampos M. Moutsopoulos (UoA: National and Kapodistrian University of Athens)H-Index: 106
view all 5 authors...
Objective To evaluate the prevalence, clinical associations, and outcome of antiphospholipid syndrome (APS) nephropathy in patients with systemic lupus erythematosus (SLE) and antiphospholipid antibodies (aPL) and in SLE patients without aPL. Methods Kidney biopsy specimens obtained from 81 patients with aPL (18 of whom had APS) and 70 patients without aPL were retrospectively examined for the presence of APS nephropathy. Clinical and serologic data obtained at the time of kidney biopsy and duri...
#1Toshitaka Sugi (Tokai University)H-Index: 18
#2Hidehiko Matsubayashi (Tokai University)H-Index: 19
Last. Tsunehisa Makino (Tokai University)H-Index: 33
view all 5 authors...
Aim: Associations have been reported between antiphospholipid antibodies (aPL), mainly anticardiolipin antibodies (aCL) and/or the lupus anticoagulant, and recurrent pregnancy losses (RPL). However, relatively few studies describing antiphosphatidylethanolamine antibodies (aPE) have been reported. We describe the prevalence of aPL to both cardiolipin and phosphatidylethanolamine in patients with RPL. Methods: Patients with recurrent early pregnancy losses (n = 145) and mid-to-late pregnancy loss...
Cited By4748
#1Laure Ricard (University of Paris)H-Index: 6
#2Charlotte Laurent (University of Paris)H-Index: 2
view all 19 authors...
Abstract null null Introduction: The antiphospholipid syndrome (APS) (1) is defined by the development of vascular thrombosis, or pregnancy morbidity in the presence of persistent antiphospholipid antibodies (aPL). Antinuclear antibodies (ANA) can be detected in primary APS patients without any clinical systemic autoimmune disease. The presence of ANA antibodies could confer a specific phenotype in primary APS. null Objective: To evaluate the characteristics of APS patients with antinuclear anti...
#1Nima RezaeiH-Index: 84
#1Jenna M. TurocyH-Index: 3
#2Zev WilliamsH-Index: 20
Last. Vikram PuttaswamyH-Index: 5
view all 4 authors...
#1Tingting Liu (SJTU: Shanghai Jiao Tong University)H-Index: 7
#2Jing Dai (SJTU: Shanghai Jiao Tong University)H-Index: 8
Last. Wenxin Xu (SJTU: Shanghai Jiao Tong University)
view all 18 authors...
The presence of antiphospholipid antibodies was shown to be associated with thrombosis in coronavirus disease 2019 (COVID-19) patients. Recently, according to reports from several studies, the vaccine-induced immune thrombotic thrombocytopenia is mediated by anti-platelet factor 4 (PF4)-polyanion complex in adenovirus-vectored COVID-19 vaccine recipients. It is impendent to explore whether inactivated COVID-19 vaccine widely used in China influences prothrombotic autoantibody production and indu...
#1Mohamed Khayata (USF: University of South Florida)
#2Tom Kai Ming Wang (Cleveland Clinic)H-Index: 6
Last. Bo Xu (Cleveland Clinic)H-Index: 11
view all 9 authors...
Systemic lupus erythematous (SLE) is an autoimmune disease with a wide range of cardiovascular complications. The main manifestations include diseases of the coronary arteries, valves, pericardium, and myocardium. Multimodality cardiovascular imaging techniques are critical for evaluating the extent of cardiac manifestations in SLE patients, which can provide valuable prognostic information. However, their utility has previously not been well-defined. This review provides a state-of-the-art upda...
#1Leonardo BiscettiH-Index: 8
#2Gioacchino De Vanna (University of Perugia)H-Index: 1
Last. Paola Sarchielli (University of Perugia)H-Index: 54
view all 8 authors...
Several lines of evidence support a role of the immune system in headache pathogenesis, with particular regard to migraine. Firstly, alterations in cytokine profile and in lymphocyte subsets have been reported in headache patients. Secondly, several genetic and environmental pathogenic factors seem to be frequently shared by headache and immunological/autoimmune diseases. Accordingly, immunological alterations in primary headaches, in particular in migraine, have been suggested to predispose som...
#2Gökçe TuranH-Index: 3
Last. Deniz KarcaaltincabaH-Index: 12
view all 6 authors...
#1Katrien Devreese (Ghent University Hospital)H-Index: 31
#2Stéphane Zuily (University of Lorraine)H-Index: 8
Last. Pier Luigi MeroniH-Index: 102
view all 3 authors...
Abstract null null The diagnosis of antiphospholipid syndrome (APS) relies on the detection of antiphospholipid antibodies (aPL). Currently, lupus anticoagulant (LA), anticardiolipin (aCL), and antibeta2-glycoprotein I antibodies (aβ2GPI) IgG or IgM are included as laboratory criteria, if persistently present. LAC measurement remains a complicated procedure with many pitfalls and interfered by anticoagulant therapy. Solid-phase assays for aCL and aβ2GPI show interassay differences. These methodo...
#1Lavinia Agra Coletto (University of Milan)H-Index: 2
#2Maria Gerosa (University of Milan)H-Index: 29
Last. Cecilia Beatrice Chighizola (University of Milan)H-Index: 24
view all 7 authors...
Anti-phospholipid antibodies (aPL) are the serological biomarkers of anti-phospholipid syndrome (APS), an autoimmune disorder characterized by vascular events and/or pregnancy morbidity. APS is a unique condition as thrombosis might occur in arterial, venous or capillary circulations. The heart provides a frequent target for circulating aPL, leading to a wide variety of clinical manifestations. The most common cardiac presentation in APS, valvular involvement, acknowledges a dual etiology compri...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.